Lista de obras - Atanaska Elenkova - Dominio Público Uruguay

Adiponectin - A possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma

artículo científico publicado en 2010

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism.

artículo científico publicado en 2016

Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma

artículo científico publicado en 2013

Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study

artículo científico

Causes and Metabolic Consequences of Gynecomastia in Adult Patients

artículo científico publicado en 2019

Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment

artículo científico publicado en 2004

Cushing's Syndrome: A Historic Review of the Treatment Strategies and Corresponding Outcomes in a Single Tertiary Center over the Past Half-Century.

artículo científico publicado en 2018

Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire

artículo científico publicado en 2015

Diurnal blood pressure pattern in patients with primary aldosteronism

artículo científico publicado en 2006

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results

artículo científico publicado en 2014

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

artículo científico publicado en 2011

High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centre.

artículo científico publicado en 2016

Homocysteine, renin and aldosterone in patients with Cushing's syndrome

artículo científico publicado en 2008

Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment

scientific article published on 16 April 2012

Long-term follow-up of a female patient with non-classical 11β-hydroxylase deficiency and two novel mutations in CYP11B1

scientific article published on 17 June 2018

Macroprolactinemia in a Patient with Invasive Macroprolactinoma: A Case Report and Minireview ⬇️

artículo científico publicado el 15 de enero de 2013

Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance

artículo científico publicado en 2013

Transforming growth factor β1 is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study).

artículo científico publicado en 2013

Treatment outcome results from the Bulgarian Acromegaly Database: adjuvant dopamine agonist therapy is efficient in less than one fifth of non-irradiated patients

artículo científico publicado en 2015

Lista de obras de Atanaska Elenkova

Adiponectin - A possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism.

Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma

Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study

Causes and Metabolic Consequences of Gynecomastia in Adult Patients

Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment

Cushing's Syndrome: A Historic Review of the Treatment Strategies and Corresponding Outcomes in a Single Tertiary Center over the Past Half-Century.

Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire

Diurnal blood pressure pattern in patients with primary aldosteronism

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centre.

Homocysteine, renin and aldosterone in patients with Cushing's syndrome

Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment

Long-term follow-up of a female patient with non-classical 11β-hydroxylase deficiency and two novel mutations in CYP11B1

Macroprolactinemia in a Patient with Invasive Macroprolactinoma: A Case Report and Minireview ⬇️

Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance

Transforming growth factor β1 is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study).

Treatment outcome results from the Bulgarian Acromegaly Database: adjuvant dopamine agonist therapy is efficient in less than one fifth of non-irradiated patients